NewGenIvf Group Limited
NIVF
$1.80
$0.052.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -443.72% | 89.96% | 0.00% | -159.09% | 227.41% |
| Total Depreciation and Amortization | 1,834.41% | 9.41% | 0.00% | -94.91% | 503.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,568.57% | -338.64% | 0.00% | -84.83% | 137.13% |
| Change in Net Operating Assets | 18.52% | -397.13% | 0.00% | 409.49% | -556.23% |
| Cash from Operations | 17.26% | -424.30% | 0.00% | 1,109.98% | -243.63% |
| Capital Expenditure | 93.23% | -667.31% | 0.00% | 70.29% | 66.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 207.19% | -2,960.00% | 0.00% | -- | -- |
| Cash from Investing | 124.77% | -870.18% | 0.00% | 67.43% | 66.60% |
| Total Debt Issued | 704.63% | -151.80% | 0.00% | 286.52% | -62.33% |
| Total Debt Repaid | 200.00% | -3,909.38% | 0.00% | -168.09% | 200.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -106.49% | 300.00% | 0.00% | -2,415.91% | 90.44% |
| Cash from Financing | -17.49% | 427.98% | 0.00% | -722.21% | 292.09% |
| Foreign Exchange rate Adjustments | 111.81% | -291.00% | 0.00% | 233.12% | -317.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,100.69% | -122.15% | 0.00% | 282.35% | 142.29% |